NetworkNewsBreaks – Vivos Therapeutics Inc. (NAS
Post# of 51
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), will be presenting at the Emerging Growth Conference this week. VVOS CEO Kirk Huntsman, along with chief financial officer Brad Amman and investor relations officer Ed Loew, will host the presentation, which is scheduled for Wednesday, April 14, at 9 a.m. EDT. Interested investors can obtain a free spectator pass. In addition, a replay of the presentation will be available on the Vivos website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer